| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Klencke Barbara | Chief Medical Officer | C/O ALX ONCOLOGY HOLDINGS INC., 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO | /s/ Shelly Pinto, by power of attorney | 05 Mar 2026 | 0001647647 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALXO | Stock option (right to buy) | Award | +700,000 | $0.000000* | 700,000 | 03 Mar 2026 | Common Stock | 700,000 | $2.07 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | One-fourth of the shares subject to the option vest on February 25, 2027 and 1/48th vest monthly thereafter. |